CKD Bio Corp. (KRX:063160)
20,900
-50 (-0.24%)
At close: Dec 19, 2025
CKD Bio Market Cap
CKD Bio has a market cap or net worth of 114.66 billion as of December 19, 2025. Its market cap has decreased by -7.11% in one year.
Market Cap
114.66B
Enterprise Value
261.44B
Revenue
159.93B
Ranking
n/a
PE Ratio
n/a
Stock Price
20,900.00
Market Cap Chart
Since March 1, 2002, CKD Bio's market cap has increased from 10.15B to 114.66B, an increase of 1,030.04%. That is a compound annual growth rate of 10.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 114.66B | -5.00% |
| Dec 30, 2024 | 120.69B | -7.76% |
| Dec 28, 2023 | 130.84B | 0.21% |
| Dec 29, 2022 | 130.57B | -43.06% |
| Dec 30, 2021 | 229.31B | -47.68% |
| Dec 30, 2020 | 438.33B | 175.88% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 80.45T |
| Celltrion | 39.84T |
| ALTEOGEN | 23.05T |
| ABL Bio | 10.29T |
| SK Biopharmaceuticals | 10.10T |
| Yuhan | 8.64T |
| LigaChem Biosciences | 6.08T |
| HLB Co., Ltd. | 6.05T |